A Randomised controlled trial to compare efficacy and tolerability of Plenvu® and Picoprep® as cleansing agents before colonoscopy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-518544-21-00

Enrollment

400

Registered

2024-11-05

Start date

2022-09-01

Completion date

Unknown

Last updated

2024-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The trial is about comparing the efficacy of Plenvu with Picoprep. Both are bowel cleansing agents prior to colonoscopy. The patients to be examined are all referred to exclude colorectal cancer disease. The cleansing process is not directly related to treatment of these patients but have an effect on the visualisation of the mucosa of the bowel and thus the quality of the colonoscopy.

Brief summary

Efficacy of plenvu is not inferior to picoprep

Detailed description

Tolerability of plenvu is not inferior to picoprep

Interventions

DRUGPlenvu

DRUGPicoprep

DRUGpulver til oral opløsning

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Efficacy of plenvu is not inferior to picoprep	—

Secondary

Measure	Time frame
Tolerability of plenvu is not inferior to picoprep	—

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026